Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)
CUSIP: 45258J102
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 202,731,676
- Total 13F shares
- 95,145,471
- Share change
- -1,431,834
- Total reported value
- $1,533,747,121
- Put/Call ratio
- 206%
- Price per share
- $16.12
- Number of holders
- 183
- Value change
- -$22,890,328
- Number of buys
- 97
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45258J102:
Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
|
Company |
8.4%
from 13D/G
|
18,599,195
|
$297,587,112 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
9,500,000
|
$152,000,000 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
7,025,938
|
$112,415,008 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3.4%
|
6,878,956
|
$110,064,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.9%
|
5,848,285
|
$93,572,560 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.7%
|
5,457,881
|
$87,326,096 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.6%
|
5,200,000
|
$83,200,000 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.6%
|
3,336,250
|
$53,379,994 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
2,830,074
|
$45,281,184 | — | 30 Jun 2025 | |
| Alpine Global Management, LLC |
13F
|
Company |
1.3%
|
2,626,692
|
$42,027,072 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
2,309,061
|
$36,944,987 | — | 30 Jun 2025 | |
| Two Seas Capital LP |
13F
|
Company |
1.1%
|
2,252,772
|
$36,044,352 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.1%
|
2,137,890
|
$34,206,240 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
1,825,602
|
$29,213,106 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.74%
|
1,498,725
|
$23,979,600 | — | 30 Jun 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.64%
|
1,300,860
|
$20,813,760 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.59%
|
1,195,516
|
$19,128,256 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.59%
|
1,188,578
|
$19,017,248 | — | 30 Jun 2025 | |
| Peter Salzmann |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,552,586
mixed-class rows
|
$17,543,264 | — | 16 Apr 2025 | |
| Julia G. Butchko |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
509,682
mixed-class rows
|
$14,251,795 | — | 21 Aug 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.42%
|
844,705
|
$13,515,280 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
0.34%
|
687,662
|
$11,002,592 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.33%
|
671,284
|
$10,740,544 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.33%
|
661,146
|
$10,578,336 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.28%
|
575,383
|
$9,206,128 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.26%
|
535,066
|
$8,561,056 | — | 30 Jun 2025 | |
| Mark S. Levine |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
387,951
mixed-class rows
|
$8,124,353 | — | 20 Nov 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.24%
|
479,400
|
$7,670,400 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.24%
|
478,263
|
$7,652,208 | — | 30 Jun 2025 | |
| William L. Macias |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
426,076
mixed-class rows
|
$7,454,384 | — | 19 Feb 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.23%
|
463,600
|
$7,417,600 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.22%
|
448,515
|
$7,176,240 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
421,726
|
$6,747,616 | — | 30 Jun 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.2%
|
414,800
|
$6,636,800 | — | 30 Jun 2025 | |
| Eva Renee Barnett |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
521,954
mixed-class rows
|
$5,907,965 | — | 16 Apr 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
350,392
|
$5,606,272 | — | 30 Jun 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.16%
|
322,846
|
$5,165,536 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.16%
|
317,882
|
$5,086,112 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.15%
|
298,170
|
$4,770,720 | — | 30 Jun 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.14%
|
275,000
|
$4,400,000 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
271,350
|
$4,341,600 | — | 30 Jun 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.13%
|
262,176
|
$4,194,816 | — | 30 Jun 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.13%
|
256,743
|
$4,107,888 | — | 30 Jun 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.12%
|
241,694
|
$3,867,000 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
241,400
|
$3,862,400 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.12%
|
236,966
|
$3,791,523 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.11%
|
225,099
|
$3,601,584 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.11%
|
221,500
|
$3,544,000 | — | 30 Jun 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.11%
|
213,088
|
$3,409,408 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
201,172
|
$3,218,752 | — | 30 Jun 2025 |
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2025
As of 30 Sep 2025,
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,145,471 shares.
The largest 10 holders included
FMR LLC, Deep Track Capital, LP, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, BlackRock, Inc., BAKER BROS. ADVISORS LP, T. Rowe Price Investment Management, Inc., Point72 Asset Management, L.P., STATE STREET CORP, and Two Seas Capital LP.
This page lists
183
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
167
Q3 2025 holders
183
Holder diff
16
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.